Spreadsheet: 2d9d6d7e-6b1c-4939-b22c-0a651bcfa4c3
Sheet: Sheet1

Table S1. 149 transcripts representing statistically significant (P<0.05) differences in testicular expression between three NOA subclasses | Unnamed: 1 | Unnamed: 2 | Unnamed: 3 | Unnamed: 4 | Unnamed: 5 | Unnamed: 6 | Unnamed: 7
[NAME] | Name | [NAME] | [NAME]. No. | Probe ID | Expression | Post hoc significance | Gene class
ACAT2 | acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase) | 6q25.3 | [NAME] | A_23_P383835 | OA<NOA | 1 vs. 2
ATP8A2 | ATPase, aminophospholipid transporter-like, Class I, type 8A, member 2 | 13q12-13 | NM_016529 | [NAME] | NOA<OA | 1 vs. 2
GGTLA4 | gamma-glutamyltransferase-like activity 4 | 20p11.1 | NM_080920 | A_23_P57199 | NOA<OA | 1 vs. 2
PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 | 10q23-q24 | [NAME] | A_23_P104492 | OA<NOA | 1 vs. 2
STMN1 | stathmin 1/oncoprotein 18 | 1p36.1-p35 | NM_005563 | A_23_P200866 | NOA<OA | 1 vs. 2
BTNL2 | butyrophilin-like 2 (MHC class II associated) | 6p21.3 | NM_019602 | A_23_P376686 | OA<NOA | 1 vs. 3
EID3 | E1A-like inhibitor of differentiation 3 | 12q23-q24.1 | AK098698 | A_23_P65068 | NOA<OA | 1 vs. 3
GLRX | glutaredoxin (thioltransferase) | 5q14 | NM_002064 | A_23_P69908 | OA<NOA | 1 vs. 3
HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | 1p13.1 | NM_000862 | A_23_P97173 | OA<NOA | 1 vs. 3
HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 1p13.1 | NM_000198 | A_23_P51576 | OA<NOA | 1 vs. 3
PBX4 | pre-B-cell leukemia transcription factor 4 | 19p12 | NM_025245 | A_23_P90419 | NOA<OA | 1 vs. 3
PEPP-2 | PEPP subfamily gene 2 | Xq24 | NM_032498 | A_23_P352494 | NOA<OA | 1 vs. 3
PLEK2 | pleckstrin 2 | 14q23.3 | NM_016445 | A_23_P151506 | OA<NOA | 1 vs. 3
SFRP1 | secreted frizzled-related protein 1 | 8p12-p11.1 | BC036503 | A_23_P10121 | OA<NOA | 1 vs. 3
SLC40A1 | solute carrier family 40 (iron-regulated transporter), member 1 | 2q32 | NM_014585 | A_23_P102391 | OA<NOA | 1 vs. 3
SPINT2 | serine protease inhibitor, Kunitz type, 2 | 19q13.1 | NM_021102 | A_23_P27795 | NOA<OA | 1 vs. 3
VSX1 | visual system homeobox 1 homolog, [NAME]-like (zebrafish) | 20p11.23-p11.22 | NM_014588 | A_23_P131990 | OA<NOA | 1 vs. 3
CALB2 | calbindin 2, 29kDa (calretinin) | 16q22.2 | NM_001740 | A_23_P21092 | OA<NOA | (1 vs. 2) & (1 vs. 3)
[NAME] | chondroitin beta1,4 N-acetylgalactosaminyltransferase | 8p21.3 | NM_018371 | A_23_P134835 | OA<NOA | (1 vs. 2) & (1 vs. 3)
CHST7 | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 | Xp11.23 | NM_019886 | [NAME] | OA<NOA | (1 vs. 2) & (1 vs. 3)
CYBASC3 | cytochrome b, ascorbate dependent 3 | 11q12.2 | THC1943229 | A_23_P127771 | OA<NOA | (1 vs. 2) & (1 vs. 3)
DMRT1 | doublesex and mab-3 related transcription factor 1 | 9p24.3 | NM_021951 | A_23_P169293 | NOA<OA | (1 vs. 2) & (1 vs. 3) | Male infertility
GRK5 | G protein-coupled receptor kinase 5 | 10q24-qter | NM_005308 | A_23_P12884 | OA<NOA | (1 vs. 2) & (1 vs. 3)
HIST2H2AA | histone 2, H2aa | 1q21.2 | NM_003516 | A_23_P103981 | NOA<OA | (1 vs. 2) & (1 vs. 3)
IGFBP5 | insulin-like growth factor binding protein 5 | 2q33-q36 | NM_000599 | A_23_P154115 | OA<NOA | (1 vs. 2) & (1 vs. 3)
LOC92196 | similar to death-associated protein | 2q24.1 | ENST00000309950 | A_23_P165598 | OA<NOA | (1 vs. 2) & (1 vs. 3)
MAP3K15 | mitogen-activated protein kinase kinase kinase 15 | Xp22.12 | AK122632 | A_23_P158919 | OA<NOA | (1 vs. 2) & (1 vs. 3)
MT1E | metallothionein 1E (functional) | 16q13 | [NAME] | A_23_P206724 | OA<NOA | (1 vs. 2) & (1 vs. 3)
[NAME] | metallothionein 1G | 16q13 | NM_005950 | A_23_P206701 | OA<NOA | (1 vs. 2) & (1 vs. 3)
RSPO3 | R-spondin 3 homolog ([NAME] laevis) | 6q22.33 | NM_032784 | A_23_P111402 | OA<NOA | (1 vs. 2) & (1 vs. 3)
SC4MOL | sterol-C4-methyl oxidase-like | 4q32-q34 | NM_006745 | A_23_P110184 | OA<NOA | (1 vs. 2) & (1 vs. 3)
SLC16A9 | solute carrier family 16 (monocarboxylic acid transporters), member 9 | 10q21.2 | NM_194298 | A_23_P115726 | OA<NOA | (1 vs. 2) & (1 vs. 3)
SPRR2F | small proline-rich protein 2F | 1q21-q22 | THC1856852 | A_23_P137478 | OA<NOA | (1 vs. 2) & (1 vs. 3)
TPD52L1 | tumor protein D52-like 1 | 6q22-q23 | NM_003287 | A_23_P31143 | OA<NOA | (1 vs. 2) & (1 vs. 3)
AK5 | adenylate kinase 5 | 1p31 | NM_174858 | A_23_P200015 | NOA<OA | 2 vs. 3
ANKRD21 | ankyrin repeat domain 21 | 21q11.2 | NM_174981 | A_23_P420348 | NOA<OA | 2 vs. 3
AREG | [NAME] (schwannoma-derived growth factor) | 4q13-q21 | NM_001657 | A_23_P259071 | NOA<OA | 2 vs. 3
BIRC5 | baculoviral IAP repeat-containing 5 (survivin) | 17q25 | NM_001168 | A_23_P118815 | NOA<OA | 2 vs. 3
BRCA1 | breast cancer 1, early onset | 17q21 | NM_007294 | A_23_P207400 | NOA<OA | 2 vs. 3
CCDC11 | coiled-coil domain containing 11 | 18q21.1 | NM_145020 | A_23_P384532 | NOA<OA | 2 vs. 3
[NAME] | cyclin B2 | 15q22.2 | NM_004701 | A_23_P65757 | NOA<OA | 2 vs. 3
CCNB3 | cyclin B3 | Xp11 | NM_033031 | A_23_P171107 | NOA<OA | 2 vs. 3
CKS2 | CDC28 protein kinase regulatory subunit 2 | 9q22 | NM_001827 | A_23_P71727 | NOA<OA | 2 vs. 3 | Male infertility
CSAG2 | CSAG family, member 2 | Xq28 | NM_004909 | A_23_P159637 | NOA<OA | 2 vs. 3 | CT antigens
DNCL2B | dynein, cytoplasmic, light polypeptide 2B | 16q23.3 | NM_130897 | A_23_P94840 | NOA<OA | 2 vs. 3
DUSP5 | dual specificity phosphatase 5 | 10q25 | NM_004419 | A_23_P150016 | NOA<OA | 2 vs. 3
DYDC1 | DPY30 domain containing 1 | 10q22.3 | NM_138812 | A_23_P360990 | NOA<OA | 2 vs. 3
EZH2 | enhancer of zeste homolog 2 (Drosophila) | 7q35-q36 | NM_004456 | [NAME] | NOA<OA | 2 vs. 3
[NAME] | family with sequence similarity 54, member A | 6q23.2 | NM_138419 | A_23_P253752 | NOA<OA | 2 vs. 3
FANCA | Fanconi anemia, complementation group A | 16q24.3 | NM_000135 | A_23_P206441 | NOA<OA | 2 vs. 3 | Male infertility
FBXO15 | F-box protein 15 | 18q22.3 | NM_152676 | A_23_P342709 | NOA<OA | 2 vs. 3
[NAME] | histone 1, H2al | 6p22-p21.3 | NM_003511 | A_23_P258477 | NOA<OA | 2 vs. 3
IL13RA2 | interleukin 13 receptor, alpha 2 | Xq13.1-q28 | NM_000640 | A_23_P85215 | NOA<OA | 2 vs. 3
IL23A | interleukin 23, alpha subunit p19 | 12q13.3 | NM_016584 | A_23_P76078 | NOA<OA | 2 vs. 3
LOC161931 | testis nuclear RNA-binding protein-like | 16q24.1 | NM_139174 | A_23_P49136 | NOA<OA | 2 vs. 3
MAGEA4 | melanoma antigen, family A, 4 | Xq28 | NM_002362 | A_23_P171175 | NOA<OA | 2 vs. 3 | CT antigens
MAGEC2 | melanoma antigen, family C, 2 | Xq27 | NM_016249 | A_23_P62099 | NOA<OA | 2 vs. 3 | CT antigens
MYCBP | c-myc binding protein | 1p33-p32.2 | NM_012333 | A_23_P201655 | NOA<OA | 2 vs. 3
NKX6-2 | NK6 transcription factor related, locus 2 (Drosophila) | 10q26 | NM_177400 | A_23_P86587 | NOA<OA | 2 vs. 3
NYD-SP14 | NYD-SP14 protein | 4q31.22 | NM_031956 | A_23_P92517 | NOA<OA | 2 vs. 3
OIP5 | Opa-interacting protein 5 | 15q15.1 | NM_007280 | A_23_P379614 | NOA<OA | 2 vs. 3
OVOL1 | ovo-like 1(Drosophila) | 11q13 | NM_004561 | A_23_P202810 | NOA<OA | 2 vs. 3 | Male subfertility
PIK3R3 | phosphoinositide-3-kinase, regulatory subunit, polypeptide 3 (p55, gamma) | 1p34.1 | [NAME] | A_23_P22970 | NOA<OA | 2 vs. 3
PIWIL4 | piwi-like 4 (Drosophila) | 11q21 | NM_152431 | A_23_P427760 | NOA<OA | 2 vs. 3
PPP1R2P9 | protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9 | Xp11.4-Xp11.3 | NM_025210 | A_23_P34007 | NOA<OA | 2 vs. 3
RAD9B | RAD9 homolog B (S. cerevisiae) | 12q24.11 | NM_152442 | A_23_P333650 | NOA<OA | 2 vs. 3
RIBC2 | [NAME] domain with coiled-coils 2 | 22q13.31 | NM_015653 | A_23_P166526 | NOA<OA | 2 vs. 3
SLC25A31 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 | 4q28.1 | NM_031291 | A_23_P18755 | NOA<OA | 2 vs. 3
SPA17 | sperm autoantigenic protein 17 | 11q24.2 | NM_017425 | A_23_P104876 | NOA<OA | 2 vs. 3 | CT antigens
SPANXA1 | sperm protein associated with the nucleus, X-linked, family member A1 | Xq27.1 | NM_013453 | A_23_P96300 | NOA<OA | 2 vs. 3 | CT antigens
SPATA4 | spermatogenesis associated 4 | 4q34.2 | NM_144644 | A_23_P393025 | NOA<OA | 2 vs. 3
[NAME] | serine-arginine repressor protein (35 kDa) | 6q15 | NM_080743 | A_23_P110901 | NOA<OA | 2 vs. 3
TACC3 | transforming, acidic coiled-coil containing protein 3 | 4p16.3 | NM_006342 | A_23_P212844 | NOA<OA | 2 vs. 3
TNNT1 | troponin T1, skeletal, slow | 19q13.4 | BC022086 | A_23_P56050 | NOA<OA | 2 vs. 3
TOP2A | topoisomerase (DNA) II alpha 170kDa | 17q21-q22 | NM_001067 | A_23_P118834 | NOA<OA | 2 vs. 3
TPTE2 | transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 | 13q12.11 | A_23_P219230 | A_23_P219230 | NOA<OA | 2 vs. 3
TRIM36 | tripartite motif-containing 36 | 5q22.3 | NM_018700 | A_23_P110569 | NOA<OA | 2 vs. 3
TYMS | thymidylate synthetase | 18p11.32 | NM_001071 | A_23_P50096 | NOA<OA | 2 vs. 3
UHRF1 | ubiquitin-like, containing PHD and RING finger domains, 1 | 19p13.3 | NM_013282 | A_23_P208880 | NOA<OA | 2 vs. 3
UNG2 | uracil-DNA glycosylase 2 | 5p15.2-p13.1 | NM_021147 | A_23_P92860 | NOA<OA | 2 vs. 3
ZCWPW1 | zinc finger, CW-type with PWWP domain 1 | 7q22.1 | NM_017984 | A_23_P70897 | NOA<OA | 2 vs. 3
ZNF541 | zinc finger protein 541 | 19q13.32 | NM_032255 | A_23_P50517 | NOA<OA | 2 vs. 3
ANKRD7 | ankyrin repeat domain 7 | 7q31 | NM_019644 | [NAME] | NOA<OA | (1 vs. 3) & (2 vs. 3)
ART3 | ADP-ribosyltransferase 3 | 4q21.1 | NM_001179 | A_23_P80918 | NOA<OA | (1 vs. 3) & (2 vs. 3)
BUB1 | BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) | 2q14 | NM_004336 | A_23_P124417 | NOA<OA | (1 vs. 3) & (2 vs. 3)
CDC45L | CDC45 cell division cycle 45-like (S. cerevisiae) | 22q11.21 | NM_003504 | A_23_P57379 | NOA<OA | (1 vs. 3) & (2 vs. 3)
[NAME] | cell division cycle associated 2 | 8p21.2 | NM_152562 | A_23_P385861 | NOA<OA | (1 vs. 3) & (2 vs. 3)
CDCA5 | cell division cycle associated 5 | 11q12.1 | NM_080668 | A_23_P104651 | NOA<OA | (1 vs. 3) & (2 vs. 3)
CDT1 | DNA replication factor | 16q24.3 | NM_030928 | A_23_P37704 | NOA<OA | (1 vs. 3) & (2 vs. 3)
CT45-2 | cancer/testis antigen CT45-2 | [NAME] | NM_152582 | A_23_P362076 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
CTAG1B | cancer/testis antigen 1B | Xq28 | NM_001327 | A_23_P148541 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
DAZL | deleted in azoospermia-like | 3p24.3 | NM_001351 | A_23_P212105 | NOA<OA | (1 vs. 3) & (2 vs. 3) | Male infertility
[NAME] | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 5q11.2 | NM_019039 | A_23_P256624 | NOA<OA | (1 vs. 3) & (2 vs. 3) | Male infertility
DDX43 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 | 6q12-q13 | NM_018665 | A_23_P156445 | NOA<OA | (1 vs. 3) & (2 vs. 3)
DMRTB1 | DMRT-like family B with proline-rich C-terminal, 1 | 1p32.3 | NM_033067 | A_23_P417821 | NOA<OA | (1 vs. 3) & (2 vs. 3)
DMRTC2 | DMRT-like family C2 | 19q13.2 | NM_033052 | A_23_P300245 | NOA<OA | (1 vs. 3) & (2 vs. 3)
DSCR8 | Down syndrome critical region gene 8 | 21q22.2 | NM_032589 | A_23_P6252 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
EGR4 | early growth response 4 | 2p13 | NM_001965 | A_23_P380318 | NOA<OA | (1 vs. 3) & (2 vs. 3) | Male infertility
FGFR3 | fibroblast growth factor receptor 3 ([NAME], thanatophoric dwarfism) | 4p16.3 | NM_000142 | A_23_P500501 | NOA<OA | (1 vs. 3) & (2 vs. 3)
FKBP6 | FK506 binding protein 6, 36kDa | 7q11.23 | NM_003602 | A_23_P250874 | NOA<OA | (1 vs. 3) & (2 vs. 3) | Male infertility
FMR1NB | fragile X mental retardation 1 neighbor | Xq27.3-q28 | NM_152578 | A_23_P396112 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
GAGE4 | G antigen 4 | Xp11.4-p11.2 | NM_001474 | A_23_P217196 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
GAJ | GAJ protein | 4q31.3 | NM_032117 | A_23_P133123 | NOA<OA | (1 vs. 3) & (2 vs. 3)
HIST1H2AA | histone 1, H2aa | 6p22.2 | NM_170745 | A_23_P355439 | NOA<OA | (1 vs. 3) & (2 vs. 3)
HIST1H2BA | histone 1, H2ba | 6p22.2 | NM_170610 | A_23_P323821 | NOA<OA | (1 vs. 3) & (2 vs. 3)
HNRNPG-T | testes-specific heterogenous nuclear ribonucleoprotein G-T | 11p15 | NM_014469 | A_23_P61967 | NOA<OA | (1 vs. 3) & (2 vs. 3)
HORMAD1 | HORMA domain containing protein | 1q21.2 | NM_032132 | A_23_P327530 | NOA<OA | (1 vs. 3) & (2 vs. 3)
INHBB | inhibin, beta B (activin AB beta polypeptide) | 2q14.2 | NM_002193 | A_23_P153964 | NOA<OA | (1 vs. 3) & (2 vs. 3)
LOC93081 | hypothetical protein BC015148 | 13q33.1 | NM_138779 | A_23_P362046 | NOA<OA | (1 vs. 3) & (2 vs. 3)
[NAME] | similar to alpha tubulin | 2q21.1 | NM_207312 | A_23_P56736 | NOA<OA | (1 vs. 3) & (2 vs. 3)
[NAME] | hypothetical LOC158812 | Xq27.3 | XM_088679 | A_23_P255457 | NOA<OA | (1 vs. 3) & (2 vs. 3)
LOC255313 | hypothetical protein LOC255313 | Xq24 | NM_173571 | [NAME] | NOA<OA | (1 vs. 3) & (2 vs. 3)
LOC339903 | hypothetical protein LOC339903 | 3p22.1 | BC041820 | A_23_P80551 | NOA<OA | (1 vs. 3) & (2 vs. 3)
MAGEA2 | melanoma antigen, family A, 2 | Xq28 | NM_005361 | A_23_P148255 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
MAGEA9 | melanoma antigen, family A, 9 | Xq28 | NM_005365 | A_23_P85094 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
MGC35212 | hypothetical protein MGC35212 | 16p13.3 | NM_152764 | A_23_P398545 | NOA<OA | (1 vs. 3) & (2 vs. 3)
MGC40042 | similar to mouse meiosis defective 1 gene | 22q13.2 | AK093341 | A_23_P211561 | NOA<OA | (1 vs. 3) & (2 vs. 3)
MTL5 | metallothionein-like 5, testis-specific (tesmin) | 11q13.2-q13.3 | NM_004923 | A_23_P161507 | NOA<OA | (1 vs. 3) & (2 vs. 3)
NMES1 | normal mucosa of esophagus specific 1 | 15q21.1 | NM_032413 | A_23_P26024 | NOA<OA | (1 vs. 3) & (2 vs. 3)
NYD-SP20 | testes development-related NYD-SP20 | 17p13.3 | NM_032598 | A_23_P101084 | NOA<OA | (1 vs. 3) & (2 vs. 3)
OTEX | paired-like homeobox protein OTEX | Xq24 | NM_139282 | A_23_P85083 | NOA<OA | (1 vs. 3) & (2 vs. 3)
PAGE1 | P antigen family, member 1 (prostate associated) | Xp11.23 | NM_003785 | A_23_P171104 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
[NAME] | P antigen family, member 5 | Xp11.21 | NM_130467 | A_23_P22744 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
PASD1 | PAS domain containing 1 | Xq28 | NM_173493 | A_23_P404057 | NOA<OA | (1 vs. 3) & (2 vs. 3)
PEPP-2 | PEPP subfamily gene 2 | Xq24 | AL590524 | A_23_P73677 | NOA<OA | (1 vs. 3) & (2 vs. 3)
RACGAP1 | Rac GTPase activating protein 1 | 12q13.12 | NM_013277 | A_23_P65110 | NOA<OA | (1 vs. 3) & (2 vs. 3)
RAD54L | RAD54-like (S. cerevisiae) | 1p32 | NM_003579 | A_23_P74115 | NOA<OA | (1 vs. 3) & (2 vs. 3)
RECQL4 | [NAME] protein-like 4 | 8q24.3 | NM_004260 | A_23_P71558 | NOA<OA | (1 vs. 3) & (2 vs. 3)
SPAG5 | sperm associated antigen 5 | 17q11.2 | NM_006461 | A_23_P89509 | NOA<OA | (1 vs. 3) & (2 vs. 3)
SPINK2 | serine protease inhibitor, [NAME] type 2 (acrosin-trypsin inhibitor) | 4q12 | NM_021114 | A_23_P155688 | NOA<OA | (1 vs. 3) & (2 vs. 3)
SSX3 | synovial sarcoma, X breakpoint 3 | Xp11.23 | NM_021014 | A_23_P252025 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
SSX6 | synovial sarcoma, X breakpoint 6 | Xp11.2 | NM_173357 | A_23_P33881 | NOA<OA | (1 vs. 3) & (2 vs. 3)
STAG3 | stromal antigen 3 | 7q22.1 | NM_012447 | A_23_P145657 | NOA<OA | (1 vs. 3) & (2 vs. 3)
SYCP3 | synaptonemal complex protein 3 | 12q23.2 | NM_153694 | A_23_P76374 | NOA<OA | (1 vs. 3) & (2 vs. 3) | Male infertility
TEX14 | testis expressed sequence 14 | 17q22 | NM_031272 | A_23_P54996 | NOA<OA | (1 vs. 3) & (2 vs. 3) | Male infertility
TEX101 | testis expressed sequence 101 | 19q13.31 | NM_031451 | A_23_P130906 | NOA<OA | (1 vs. 3) & (2 vs. 3)
TKTL1 | transketolase-like 1 | Xq28 | NM_012253 | A_23_P259901 | NOA<OA | (1 vs. 3) & (2 vs. 3)
TPTE | [NAME] phosphatase with tensin homology | 21p11 | A_23_P88012 | A_23_P88012 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
TPTE | [NAME] phosphatase with tensin homology | 21p11 | NM_013315 | A_23_P345746 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
TSPY1 | testis specific protein, Y-linked 1 | Yp11.2 | NM_003308 | A_23_P22800 | NOA<OA | (1 vs. 3) & (2 vs. 3)
[NAME] | testis specific protein, Y-linked 2 | Yp11.2 | NM_022573 | A_23_P251391 | NOA<OA | (1 vs. 3) & (2 vs. 3)
[NAME] | testis specific protein, Y-linked 2 | Yp11.2 | NM_022573 | A_23_P34200 | NOA<OA | (1 vs. 3) & (2 vs. 3)
VCX | variable charge, X-linked | Xp22 | NM_013452 | A_23_P252572 | NOA<OA | (1 vs. 3) & (2 vs. 3)
VCX2 | variable charge, X-linked 2 | Xp22.32 | NM_016378 | A_23_P114243 | NOA<OA | (1 vs. 3) & (2 vs. 3)
[NAME] | variable charge, X-linked 3 | Xp22 | NM_016379 | A_23_P171188 | NOA<OA | (1 vs. 3) & (2 vs. 3)
VCY | variable charge, Y-linked | Yq11.221 | NM_004679 | A_23_P11390 | NOA<OA | (1 vs. 3) & (2 vs. 3)
XAGE3 | X antigen family, member 3 | [NAME] | NM_130776 | A_23_P114343 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
XAGE5 | X antigen family, member 5 | [NAME] | NM_130775 | A_23_P301497 | NOA<OA | (1 vs. 3) & (2 vs. 3) | CT antigens
XAGE1 | X antigen family, member 1 | [NAME] | NM_133431 | A_23_P383310 | NOA<OA | all comparisons | CT antigens
The 53 transcripts with highly significant (P<0.01) expression differences between NOA subclasses are shown in boldface.